Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
Checkpoint inhibition less toxic than antiangiogenic therapy in NSCLC
ORLANDO – Checkpoint blockade associated with less combined direct and indirect toxicity, a systematic review and meta-analysis suggests.
News
HDAC inhibition may boost immune therapy efficacy in breast cancer
ORLANDO – Entinostat and nivolumab with or without ipilimumab showed encouraging activity in early results from a phase 1 trial of patients with...
News
Sling revisions: pain as indication linked with SUI recurrence
ORLANDO – Pain as an indication for midurethral sling revision is associated with an elevated risk of postoperative SUI, according to a review of...
News
CBC data can predict immunotherapy responses in NSCLC
ORLANDO – Readily available complete blood count data can help predict response to immunotherapy in patients with advanced NSCLC.
News
Xenon imaging could detect lung involvement after HSCT
SALT LAKE CITY – Non-ionizing imaging technique could reveal early lung ventilation deficits in children undergoing hematopoietic stem cell...
News
Survey: Litigation fears drive response to FDA power morcellator warnings
ORLANDO – A survey suggests a 2014 FDA power morcellation warning led to a sharp decline in its use, driven largely by fears of litigation vs....
News
High MIH case volume may up risk for adverse events in women with large uteri
ORLANDO – High case volume for surgeons performing MIH with large uteri is linked with a decreased rate of conversion to laparotomy.
News
Laparoscopic hysterectomy safest even for markedly enlarged uteri
ORLANDO – The complication rate is lower with laparoscopic hysterectomy than with abdominal or vaginal hysterectomy – even among women with uteri...
News
KD025 shows promise for steroid-dependent cGVHD
SALT LAKE CITY – The ROCK2-selective inhibitor KD025 is demonstrating encouraging activity and safety in steroid-dependent cGVHD in a phase 2a...
News
MEC plus ixazomib looks promising in relapsed/refractory AML
ATLANTA – The findings suggest that results from gene expression profiling could help identify resistant patients.
News
HCT-CI score may predict mortality for nonmalignant disease
SALT LAKE CITY – The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) is useful in hematologic malignancies, but it may also be...
News
GCLAM therapy shows promise for relapsed/refractory AML
ATLANTA – The phase 1/2 trial evaluated combined G-CSF, cladribine, high-dose cytarabine, and mitoxantrone in adults with relapsed/refractory AML...
News
Team engagement and motivation critical to QI success
Behavioral change is one of the greatest challenges of quality improvement, says veteran QI leader Dr. Thomas McIlraith.
News
High objective response rate, OS seen with ATA129 in PTLD
SALT LAKE CITY, UTAH – The findings confirm those from prior single-center studies.
News
‘Remarkable’ survival seen with pretransplant JAK inhibitor
SALT LAKE CITY – Pretransplant JAK inhibitor therapy may improve posttransplant survival in patients with myelofibrosis, according to a phase 2...